Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J grabs prostate cancer rights for Tesaro's niraparib in $500M deal
J&J grabs prostate cancer rights for Tesaro's niraparib in $500M deal
J&J grabs prostate cancer rights for Tesaro's niraparib in $500M deal
Submitted by
admin
on April 6, 2016 - 9:51am
Source:
Fierce Biotech
News Tags:
JNJ
prostate cancer
Tesaro
niraparib
Headline:
J&J grabs prostate cancer rights for Tesaro's niraparib in $500M deal
Do Not Allow Advertisers to Use My Personal information
